Stock listing
BOATS:NGNE Neurogene Inc. Stock
US listing (BOATS) of Neurogene Inc. · home listing NASDAQ:NGNE
Follow Neurogene Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NGNE
$26.61 USD -0.94 (-3.4%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NGNE
- Day range
- $26.47 – $29.23 USDNov 2, 2026
- Volume
- 173,618 sharesNov 2, 2026
- Market cap
- $532.5M USDAt the close on Nov 2, 2026 · price × 20.01M shares outstanding
- 52-week range
- $15.93 – $43.66 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $9.07M USDMedian day 205,897 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NGNE · Home | $26.61 USD | -0.94 (-3.4%) | 173,618 | $27.85 | $29.23 | $26.47 | $27.55 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:NGNE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.61 | -0.94 | -3.4% | $27.85 | $29.23 | $26.47 | 173,618 | |
| $27.55 | -1.27 | -4.4% | $28.53 | $29.38 | $26.77 | 249,044 | |
| $28.82 | -1.60 | -5.3% | $30.50 | $32.09 | $28.50 | 309,992 | |
| $30.42 | +3.43 | +12.7% | $26.99 | $31.14 | $25.81 | 646,309 | |
| $26.99 | +3.45 | +14.7% | $23.71 | $27.23 | $23.26 | 484,939 | |
| $23.54 | -0.01 | 0.0% | $23.75 | $24.43 | $23.32 | 123,200 | |
| $23.55 | -0.73 | -3.0% | $24.11 | $24.11 | $23.08 | 124,512 | |
| $24.28 | -1.80 | -6.9% | $25.74 | $26.38 | $24.09 | 212,380 | |
| $26.08 | +0.68 | +2.7% | $25.52 | $26.94 | $25.11 | 588,807 | |
| $25.40 | +1.23 | +5.1% | $24.20 | $25.84 | $23.80 | 205,897 | |
| $24.17 | +0.92 | +4.0% | $23.26 | $24.39 | $22.78 | 240,177 | |
| $23.25 | -0.70 | -2.9% | $24.00 | $24.27 | $23.00 | 571,531 | |
| $23.95 | +1.77 | +8.0% | $22.35 | $24.41 | $22.35 | 587,986 | |
| $22.18 | +0.62 | +2.9% | $21.05 | $22.50 | $21.05 | 522,546 | |
| $21.56 | -2.88 | -11.8% | $24.32 | $25.17 | $21.40 | 442,253 | |
| $24.44 | -1.96 | -7.4% | $26.13 | $27.15 | $24.19 | 388,006 | |
| $26.40 | -0.10 | -0.4% | $28.90 | $29.63 | $26.01 | 465,903 | |
| $26.50 | +0.63 | +2.4% | $28.00 | $28.97 | $26.24 | 509,475 | |
| $25.87 | +0.42 | +1.7% | $25.14 | $26.01 | $25.01 | 114,069 | |
| $25.45 | -1.02 | -3.9% | $26.63 | $26.74 | $25.04 | 121,651 | |
| $26.47 | +0.82 | +3.2% | $25.71 | $26.76 | $24.87 | 211,773 | |
| $25.65 | -0.90 | -3.4% | $26.95 | $26.95 | $24.86 | 401,641 | |
| $26.55 | -1.27 | -4.6% | $27.68 | $28.54 | $26.44 | 182,600 | |
| $27.82 | -0.57 | -2.0% | $28.52 | $28.62 | $27.40 | 160,126 | |
| $28.39 | -0.09 | -0.3% | $28.50 | $29.16 | $28.05 | 176,742 | |
| $28.48 | +0.17 | +0.6% | $28.20 | $28.82 | $27.64 | 176,387 | |
| $28.31 | -2.94 | -9.4% | $31.31 | $31.31 | $28.23 | 200,108 | |
| $31.25 | +0.32 | +1.0% | $30.85 | $31.78 | $30.43 | 374,883 | |
| $30.93 | -2.67 | -7.9% | $33.49 | $33.53 | $30.09 | 276,187 | |
| $33.60 | +1.03 | +3.2% | $32.94 | $34.45 | $32.79 | 1,223,247 | |
| $32.57 | +0.48 | +1.5% | $32.09 | $32.84 | $31.21 | 325,534 | |
| $32.09 | -0.32 | -1.0% | $32.49 | $33.15 | $31.86 | 1,388,879 | |
| $32.41 | -2.26 | -6.5% | $35.36 | $35.64 | $32.04 | 171,608 | |
| $34.67 | +0.98 | +2.9% | $34.04 | $34.86 | $33.53 | 232,132 | |
| $33.69 | -1.52 | -4.3% | $35.04 | $35.04 | $33.46 | 147,611 | |
| $35.21 | -0.27 | -0.8% | $35.92 | $36.28 | $34.70 | 194,666 | |
| $35.48 | -0.64 | -1.8% | $36.50 | $37.64 | $35.38 | 181,388 | |
| $36.12 | -1.76 | -4.6% | $37.51 | $38.25 | $36.07 | 177,111 | |
| $37.88 | -0.25 | -0.7% | $38.04 | $40.42 | $37.86 | 193,179 | |
| $38.13 | -0.47 | -1.2% | $37.79 | $38.75 | $36.68 | 228,474 | |
| $38.60 | +0.99 | +2.6% | $37.25 | $39.38 | $36.56 | 205,633 | |
| $37.61 | -0.75 | -2.0% | $38.74 | $39.19 | $36.65 | 255,221 | |
| $38.36 | +0.49 | +1.3% | $37.97 | $39.78 | $36.86 | 252,961 | |
| $37.87 | +1.63 | +4.5% | $35.80 | $38.21 | $35.31 | 134,478 | |
| $36.24 | -0.34 | -0.9% | $36.13 | $36.64 | $35.26 | 120,388 | |
| $36.58 | -1.28 | -3.4% | $37.68 | $38.56 | $36.32 | 132,795 | |
| $37.86 | -0.55 | -1.4% | $38.50 | $39.81 | $37.39 | 149,922 | |
| $38.41 | -2.43 | -6.0% | $40.74 | $41.77 | $38.27 | 180,171 | |
| $40.84 | +1.20 | +3.0% | $40.09 | $42.01 | $39.13 | 504,339 | |
| $39.64 | +1.01 | +2.6% | $38.64 | $40.82 | $37.50 | 439,100 | |
| $38.63 | +0.64 | +1.7% | $38.41 | $39.44 | $37.54 | 346,580 | |
| $37.99 | -1.44 | -3.7% | $38.55 | $38.60 | $36.78 | 124,693 | |
| $39.43 | +3.76 | +10.5% | $36.85 | $40.16 | $35.90 | 383,100 | |
| $35.67 | -1.01 | -2.8% | $36.35 | $36.99 | $35.21 | 88,444 | |
| $36.68 | +0.54 | +1.5% | $36.14 | $37.18 | $35.42 | 91,130 | |
| $36.14 | +0.51 | +1.4% | $35.44 | $36.40 | $34.47 | 115,860 | |
| $35.63 | -1.35 | -3.7% | $37.24 | $38.00 | $35.47 | 140,294 | |
| $36.98 | +1.18 | +3.3% | $36.59 | $37.28 | $35.72 | 342,639 | |
| $35.80 | -0.75 | -2.1% | $36.19 | $36.27 | $30.57 | 352,606 | |
| $36.55 | +0.86 | +2.4% | $35.68 | $36.89 | $35.19 | 214,307 | |
| $35.69 | +0.09 | +0.3% | $36.02 | $36.68 | $34.60 | 103,221 | |
| $35.60 | -0.38 | -1.1% | $36.01 | $36.50 | $35.38 | 94,292 | |
| $35.98 | +1.57 | +4.6% | $34.66 | $36.30 | $34.36 | 167,581 | |
| $34.41 | +1.54 | +4.7% | $33.01 | $34.62 | $33.01 | 142,210 | |
| $32.87 | -0.02 | -0.1% | $33.52 | $33.69 | $31.86 | 155,549 |
- Ticker
- BOATS:NGNE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Neurogene Presents New Data at ESGCT Congress that Reinforce Key Differentiators of NGN-401 Gene Therapy for Rett Syndrome
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 37 slides
Calls
Replays
Neoleukin Therapeutics, Inc. (NLTX) Q2 2022 Earnings Call
Tue, Aug 09, 2022 · 4:30 PM ET
Watch TranscriptNeoleukin Therapeutics, Inc. (NLTX) Q4 2021 Earnings Call
Tue, Mar 01, 2022 · 4:30 PM ET
Watch Transcript
Latest news
Neurogene Presents New Data at ESGCT Congress that Reinforce Key Differentiators of NGN-401 Gene Therapy for Rett Syndrome
Oct 27, 2026
Closed $26.99 (+14.7%) on Oct 27, 2026
Neurogene Announces Upcoming Presentations Highlighting Key Differentiators of NGN-401 for Rett Syndrome at the ESGCT 33rd Annual Congress
Oct 20, 2026
Closed $25.40 (+5.1%) on Oct 20, 2026
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 5, 2026
Closed $25.45 (-3.9%) on Oct 6, 2026
Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $38.13 (-1.2%) on Sep 8, 2026
Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
Aug 11, 2026
Closed $35.80 (-2.1%) on Aug 11, 2026
Neurogene Inc. Announces Pricing of $125 Million Public Offering
Jul 1, 2026
Closed $33.88 (+7.7%) on Jul 1, 2026
Neurogene Inc. Announces Proposed Public Offering
Jun 30, 2026
Closed $33.88 (+7.7%) on Jul 1, 2026
Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome
Jun 29, 2026
Closed $32.28 (+0.8%) on Jun 29, 2026
Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
Jun 8, 2026
Closed $28.60 (+8.0%) on Jun 8, 2026
Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates
May 12, 2026
Closed $32.62 (+3.4%) on May 13, 2026
Financings
Public offering of shares
Aug 11, 2026
Closed: US$144M raised
Decks
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Technical Presentation (June 2026)
Technical · 38 slides · Jun 29, 2026
Investor Presentation (June 2026)
Investor deck · 33 slides · Jun 8, 2026
Investor Presentation (May 2026)
Investor deck · 33 slides · May 12, 2026
Neurogene Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 101 in all · newest Oct 27, 2026 · oldest 2020
- Calls
- 2 calls with a replay · 2 with a transcript · latest Aug 9, 2022
- Decks
- 25 decks · latest August 2026
Where Neurogene Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NGNE · Home listing | NASDAQ | United States | USD |
| LS Exchange:A3EX79 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3EX79 | Lang & Schwarz | Germany | EUR |
| BOATS:NGNE · This page | BOATS | United States | USD |
| Frankfurt:UU8 | Frankfurt | Germany | EUR |
| Dusseldorf:UU8 | Dusseldorf | Germany | EUR |
| Tradegate:UU8 | Tradegate | Germany | EUR |
| Stuttgart:UU8 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Neurogene Inc.